- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Zanaflex
Synonyms :
tizanidine
Class :
Alpha2 Adrenergic Agonists
Dosage Forms & Strengths
Capsule
2mg
4mg
6mg
Tablet
2mg
4mg
Indicated for Muscle Spasticity:
Initial dose: 2mg orally thrice a day whenever necessary. Do not exceed three doses per day
Maintenance dose: Adjust dosage in increments of 2 to 4 mg daily, with a minimum interval of 1 to 4 days between dose adjustments, until the desired effect is achieved.
Do not exceed 36mg/day.
To gradually discontinue, reduce by 2-4 mg daily.
Dose Adjustments
Renal Impairment
CrCl <25 mL/min: Clearance decreased >50%
Creatinine Clearance Rate (CrCl) >25 mL/min: Not Studied; Caution Is Advised
Safety and Efficacy not established.
Refer adult dosing
may increase the hypotensive effect of blood pressure-lowering agents
may increase the AV blocking effect of alpha2 agonists
may increase the CNS depressant effect of CNS depressants
may increase the bradycardic effect of bradycardia causing agents
may increase the CNS depressant effect of CNS depressants
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the bradycardic effect of bradycardia causing agents
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may decrease the hypertensive effect of alpha two agonists
may increase the hypotensive effect of blood pressure-lowering agents
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the bradycardic effect of bradycardia causing agents
may increase the toxic effect of CNS depressants
may increase the bradycardic effect of bradycardia, causing agents
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP1A2 inhibitors
may increase the AV-blocking effect of beta blockers
They may increase the vasopressor effect when combined with Alpha-/Beta-Agonists
It may increase the vasoconstricting effect when combined with Alpha-/Beta-Agonists
It may increase the hypertensive effect when combined with Alpha-/Beta-Agonists
may decrease the antihypertensive effect when combined with alpha2-agonists
cyproterone and ethinyl estradiol
may enhance the serum concentration of CYP1A2 Inhibitors
may increase the CNS depressant effect of CNS depressants
may increase the hypotensive effect of blood pressure-lowering agents
may increase the arrhythmogenic effect of bradycardia-causing agents
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may enhance the serum concentration of CYP1A2 substrates
may increase the CNS depressant effect of CNS depressants
may increase the hypertensive effect
ciprofloxacin inhaled (Pending FDA approval)
may diminish the serum concentration of ciprofloxacin
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may increase the av-blocking effect of beta-blockers
may increase the av-blocking effect of beta-blockers
may increase the av-blocking effect of beta-blockers
may increase the av-blocking effect of beta-blockers
may increase the av-blocking effect of beta-blockers
they increase the QTc prolongation effect of other QT-prolonging agents
they increase the QTc prolongation effect of other QT-prolonging agents
they increase the QTc prolongation effect of other QT-prolonging agents
they increase the QTc prolongation effect of other QT-prolonging agents
they increase the QTc prolongation effect of other QT-prolonging agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the CNS depressant effect of CNS depressants
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the hypotensive effect of blood pressure-lowering agents
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may enhance the QTc-prolonging effect of Moxifloxacin
may enhance the Qtc prolonging effect